ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,712.69
      -0.28%
      US Tech 100
      19,497.60
      0.29%
      Dow Jones
      41,794.60
      0.00%
      Brent Oil
      75.38
      0.35%
      Bitcoin
      68,726.91
      1.34%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexeo Therapeutics Inc (LXEO)

      7. Lexeo Therapeutics Inc (LXEO) Financials

      Lexeo Therapeutics Inc

      Lexeo Therapeutics Inc (LXEO)

      NASDAQ
      8.24
      0.31
      (3.91%)
      Closed November 04 4:00PM
      Delayed by 15 minutes
      8.24
      0.00
      ( 0.00% )
      Pre Market: 7:00AM
      Delayed by 15 minutes

      Lexeo Therapeutics Inc Financial Summary

      The current LXEO market cap is 272.42M. The company's latest EPS is USD -2.0082 and P/E is -4.10.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -14.97M-23.29M-23.55M
      Net Income -14.19M-21.68M-21.24M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 1.66M654k0
      Operating Income -50.64M-60.51M-68.51M
      Net Income -50.62M-59.28M-66.39M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Assets 139.81M213.21M192.01M
      Total Liabilities 26.27M30.26M27.06M
      Total Equity 113.54M182.95M164.95M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 136.86M97.08M139.81M
      Total Liabilities 7.45M25M26.27M
      Total Equity -55.6M-112.95M113.54M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Operating -59.5M-14.87M-35.02M
      Investing -165k-193k-411k
      Financing 103.79M88.65M88.95M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -44.18M-54.56M-59.5M
      Investing -188k-901k-165k
      Financing 150.86M189k103.79M

      Stats and Ratios

      Market Cap 272.42M
      Price to Earnings Ratio -4.10
      Price to Sales Ratio 0
      Price to Cash Ratio 2.24
      Price to Book Ratio 2.4
      Dividend Yield -

      Share Statistics

      Shares Outstanding 33.06M
      Average Volume (1 week) 410.27k
      Average Volume (1 Month) 344.79k
      52 Week Change -17.60%
      52 Week High 22.33
      52 Week Low 7.54
      Spread (Intraday) 2.27 (23.23%)

      Company Info

      Company Name Lexeo Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.lexeotx.com
      Industry biological pds,ex diagnstics (2836)